Yurchenko M - Search Results

1

Expression of CD150 in tumors of the central nervous system: identification of a novel isoform.

Romanets-Korbut O, Najakshin AM, Yurchenko M, Malysheva TA, Kovalevska L, Shlapatska LM, Zozulya YA, Taranin AV, Horvat B, Sidorenko SP. Romanets-Korbut O, et al. Among authors: yurchenko m. PLoS One. 2015 Feb 24;10(2):e0118302. doi: 10.1371/journal.pone.0118302. eCollection 2015. PLoS One. 2015. PMID: 25710480 Free PMC article.

2

CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cells.

Yurchenko MY, Kovalevska LM, Shlapatska LM, Berdova GG, Clark EA, Sidorenko SP. Yurchenko MY, et al. Immunol Cell Biol. 2010 Jul;88(5):565-74. doi: 10.1038/icb.2010.14. Epub 2010 Mar 16. Immunol Cell Biol. 2010. PMID: 20231852

3

CD150-mediated Akt signalling pathway in normal and malignant B cells.

Yurchenko M, Shlapatska LM, Romanets OL, Ganshevskiy D, Kashuba E, Zamoshnikova A, Ushenin YV, Snopok BA, Sidorenko SP. Yurchenko M, et al. Exp Oncol. 2011 Mar;33(1):9-18. Exp Oncol. 2011. PMID: 21423089

4

Differential expression of PKD1 and PKD2 in gastric cancer and analysis of PKD1 and PKD2 function in the model system.

Shabelnik MY, Kovalevska LM, Yurchenko MY, Shlapatska LM, Rzepetsky Y, Sidorenko SP. Shabelnik MY, et al. Among authors: yurchenko my. Exp Oncol. 2011 Dec;33(4):206-11. Exp Oncol. 2011. PMID: 22217708

5

FCRL6 receptor: expression and associated proteins.

Kulemzin SV, Zamoshnikova AY, Yurchenko MY, Vitak NY, Najakshin AM, Fayngerts SA, Chikaev NA, Reshetnikova ES, Kashirina NM, Peclo MM, Rutkevich PN, Shevelev AY, Yanushevskaya EV, Baranov KO, Mamonkin M, Vlasik TN, Sidorenko SP, Taranin AV, Mechetina LV. Kulemzin SV, et al. Among authors: yurchenko my. Immunol Lett. 2011 Jan 30;134(2):174-82. doi: 10.1016/j.imlet.2010.09.023. Epub 2010 Oct 7. Immunol Lett. 2011. PMID: 20933011

6

Hodgkin's lymphoma: the role of cell surface receptors in regulation of tumor cell fate.

Yurchenko M, Sidorenko SP. Yurchenko M, et al. Exp Oncol. 2010 Dec;32(4):214-23. Exp Oncol. 2010. PMID: 21270747 Review.

7

The multilevel regulation of CD95 signaling outcome.

Yurchenko M, Shlapatska LM, Sidorenko SP. Yurchenko M, et al. Exp Oncol. 2012 Oct;34(3):153-9. Exp Oncol. 2012. PMID: 23069999 Review.

8

Study on the spatial architecture of p53, MDM2, and p14ARF containing complexes.

Savchenko A, Yurchenko M, Snopok B, Kashuba E. Savchenko A, et al. Among authors: yurchenko m. Mol Biotechnol. 2009 Mar;41(3):270-7. doi: 10.1007/s12033-008-9116-x. Epub 2008 Nov 7. Mol Biotechnol. 2009. PMID: 18989794

9

SPR-based immunocapture approach to creating an interfacial sensing architecture: Mapping of the MRS18-2 binding site on retinoblastoma protein.

Snopok B, Yurchenko M, Szekely L, Klein G, Kashuba E. Snopok B, et al. Among authors: yurchenko m. Anal Bioanal Chem. 2006 Dec;386(7-8):2063-73. doi: 10.1007/s00216-006-0867-6. Epub 2006 Nov 4. Anal Bioanal Chem. 2006. PMID: 17086389

10

Epstein-Barr virus-encoded EBNA-5 forms trimolecular protein complexes with MDM2 and p53 and inhibits the transactivating function of p53.

Kashuba E, Yurchenko M, Yenamandra SP, Snopok B, Szekely L, Bercovich B, Ciechanover A, Klein G. Kashuba E, et al. Among authors: yurchenko m. Int J Cancer. 2011 Feb 15;128(4):817-25. doi: 10.1002/ijc.25414. Int J Cancer. 2011. PMID: 20473904 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page